{"id":2002,"date":"2025-06-23T12:13:24","date_gmt":"2025-06-23T16:13:24","guid":{"rendered":"https:\/\/9bio.ca\/?p=2002"},"modified":"2026-01-20T09:24:53","modified_gmt":"2026-01-20T14:24:53","slug":"9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program","status":"publish","type":"post","link":"https:\/\/9biotx.com\/fr\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/","title":{"rendered":"9Bio Th\u00e9rapeutiques s\u00e9lectionn\u00e9e par le Merck Digital Sciences Studio et par le CQDM pour un investissement strat\u00e9gique et un programme d\u2019acc\u00e9l\u00e9ration"},"content":{"rendered":"

Qu\u00e9bec, QC, le 23 juin 2025<\/strong> \u2013 9Bio Th\u00e9rapeutiques, une entreprise de biotechnologie sp\u00e9cialis\u00e9e dans l\u2019ing\u00e9nierie de prot\u00e9ines th\u00e9rapeutiques conditionnellement actives pour le traitement du cancer, est fi\u00e8re d\u2019annoncer un investissement strat\u00e9gique du Merck Digital Sciences Studio (MDSS) et du CQDM. Ce financement permettra d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement de la plateforme de d\u00e9couverte guid\u00e9e par calcul de 9Bio ainsi que de son pipeline de th\u00e9rapies tumorales s\u00e9lectives.<\/p>\n\n\n\n

Cet investissement s\u2019inscrit dans le cadre de la s\u00e9lection de 9Bio au programme comp\u00e9titif MDSS, qui offre du capital et un acc\u00e8s \u00e0 une expertise mondiale aux startups biotechnologiques \u00e0 fort potentiel. Gr\u00e2ce \u00e0 cette initiative, 9Bio b\u00e9n\u00e9ficie non seulement d\u2019un appui financier, mais aussi d\u2019un acc\u00e8s direct aux experts, d\u00e9cideurs et au r\u00e9seau international de Merck \u2013 ouvrant la voie \u00e0 des collaborations \u00e0 long terme. Le programme est offert en partenariat avec Centech, un important incubateur d\u2019entreprises et p\u00f4le d\u2019innovation situ\u00e9 \u00e0 Montr\u00e9al, au Qu\u00e9bec.<\/p>\n\n\n\n

\u00ab Le fait d\u2019avoir \u00e9t\u00e9 s\u00e9lectionn\u00e9s par le programme MDSS et par le CQDM t\u00e9moigne de l\u2019int\u00e9r\u00eat croissant pour les approches novatrices en oncologie \u00bb, a d\u00e9clar\u00e9 Henrique de Carvalho, cofondateur et chef de la direction de 9Bio Th\u00e9rapeutiques. \u00ab Leur soutien renforce la confiance dans notre plateforme et notre vision de d\u00e9velopper la prochaine g\u00e9n\u00e9ration de traitements contre le cancer pour les patients ayant peu ou pas d\u2019options th\u00e9rapeutiques. \u00bb<\/p>\n\n\n\n

L\u2019approche de 9Bio int\u00e8gre la biologie computationnelle et la mod\u00e9lisation structurale afin d\u2019ing\u00e9nierie des th\u00e9rapies capables de s\u2019activer s\u00e9lectivement au site tumoral \u2013 offrant un changement de paradigme potentiel dans la conception et l\u2019administration de biologiques.<\/p>\n\n\n\n

\u00ab\u202fLe r\u00f4le de la bioinformatique d\u00e9passe les outils comme l\u2019apprentissage automatique pour inclure de nouveaux mod\u00e8les d\u2019apprentissage automatique du langage et les r\u00e9seaux neuronaux, et \u00eatre \u00e0 l\u2019avant-garde de cette \u00e9volution dans toutes les r\u00e9gions peut avoir un impact positif sur la mise au point de m\u00e9dicaments pour l\u2019industrie pharmaceutique,\u202f\u00bb a affirm\u00e9 David Rubin, directeur g\u00e9n\u00e9ral du Merck Global Health Innovation Fund.<\/p>\n\n\n\n

Philipe Gobeil, PhD, cofondateur, pr\u00e9sident et chef des sciences de 9Bio, a ajout\u00e9 : \u00ab\u202fNous construisons une plateforme qui a le potentiel de red\u00e9finir la conception et l\u2019administration des biologiques en oncologie \u2013 et ce partenariat acc\u00e9l\u00e8re notre chemin vers cet objectif.\u202f\u00bb<\/p>\n\n\n\n

Avec le soutien d\u2019un investisseur mondial de premier plan dans le domaine de la sant\u00e9 et du CQDM, 9Bio est bien positionn\u00e9e pour faire progresser sa plateforme et son portefeuille vers la prochaine phase de d\u00e9veloppement. La participation au programme MDSS n\u2019est pas exclusive, ce qui permet \u00e0 9Bio de continuer \u00e0 \u00e9tablir des partenariats strat\u00e9giques avec d\u2019autres acteurs pharmaceutiques et collaborateurs de l\u2019industrie. L\u2019entreprise est actuellement en discussions avec d\u2019autres investisseurs pour \u00e9largir son tour de financement et ainsi acc\u00e9l\u00e9rer davantage l\u2019atteinte de jalons cl\u00e9s en recherche pr\u00e9clinique et translationnelle.<\/p>\n\n\n\n

Lisez le communiqu\u00e9 officiel de Merck ici<\/a>.<\/p>\n\n\n\n

\n\n\n\n

\u00c0 propos de 9Bio Th\u00e9rapeutiques<\/strong><\/p>\n\n\n\n

9Bio est une entreprise de biotechnologie d\u00e9di\u00e9e au d\u00e9veloppement de th\u00e9rapies oncologiques innovantes. Notre plateforme de biologie structurale guid\u00e9e par l'IA int\u00e8gre des contextes anatomiques et biochimiques pour concevoir des m\u00e9dicaments ciblant s\u00e9lectivement les tumeurs. Gr\u00e2ce \u00e0 cette approche, nous d\u00e9veloppons des traitements sp\u00e9cifiquement dirig\u00e9s contre les tumeurs, tout en pr\u00e9servant les tissus sains, am\u00e9liorant ainsi la s\u00e9curit\u00e9, l\u2019efficacit\u00e9 et ouvrant la voie \u00e0 des modalit\u00e9s th\u00e9rapeutiques jusqu\u2019ici sous-exploit\u00e9es. Notre pipeline comprend deux th\u00e9rapies en phase de d\u00e9couverte : un conjugu\u00e9 anticorps-m\u00e9dicament (ADC) ciblant les cellules tumorales chimior\u00e9sistantes et un autre ADC ciblant les cellules immunitaires subverties par les tumeurs.<\/p>\n\n\n\n

\u00c0 propos de Merck Digital Science Studio<\/strong><\/p>\n\n\n\n

Le Merck Digital Sciences Studio (MDS Studio ou MDSS) est un programme d\u2019acc\u00e9l\u00e9ration offrant du mentorat, de l\u2019encadrement, de la formation, du soutien, de la communaut\u00e9 et des investissements afin d\u2019ouvrir la voie \u00e0 la prochaine g\u00e9n\u00e9ration de technologies novatrices en vue de la d\u00e9couverte et de la mise au point de m\u00e9dicaments. Nous investissons dans des startups perturbatrices et novatrices dans le domaine de la biopharmacie num\u00e9rique par l\u2019entremise d\u2019un SAFE (Accord simple pour des actions futures). La conception et le r\u00e9seau uniques du MDS Studio permettent aux entreprises en d\u00e9marrage de s\u2019engager avec des partenaires de premier plan de l\u2019industrie, qui jouent un r\u00f4le actif dans le d\u00e9veloppement. Pour en savoir plus, visitez www.mds.studio<\/a>.<\/p>\n\n\n\n

\u00c0 propos de Merck<\/strong><\/p>\n\n\n\n

Chez Merck, connue sous le nom de MSD \u00e0 l\u2019ext\u00e9rieur des \u00c9tats-Unis et du Canada, nous unissons nos forces autour de notre raison d\u2019\u00eatre : nous utilisons la puissance des m\u00e9thodes scientifiques de pointe pour sauver des vies et en am\u00e9liorer partout dans le monde. Depuis plus de 130 ans, nous donnons espoir \u00e0 l\u2019humanit\u00e9 en mettant au point des m\u00e9dicaments et des vaccins importants. Nous aspirons \u00e0 devenir la premi\u00e8re soci\u00e9t\u00e9 biopharmaceutique de recherche intensive au monde \u2013 et nous sommes aujourd\u2019hui \u00e0 l\u2019avant-garde de la recherche, offrant des solutions de sant\u00e9 innovatrices qui font progresser la pr\u00e9vention et le traitement des maladies chez les humains et les animaux. Nous encourageons la diversit\u00e9 et l\u2019inclusivit\u00e9 de notre main-d\u2019oeuvre au niveau mondial et agissons de mani\u00e8re responsable chaque jour pour permettre un avenir s\u00fbr, durable et sain pour toutes les personnes et toutes les communaut\u00e9s. Pour plus d\u2019informations sur nos activit\u00e9s au Canada, visitez www.merck.ca<\/a> et rejoignez-nous sur LinkedIn<\/a> @MerckCanada.<\/p>\n\n\n\n

\u00c0 propos du CQDM<\/strong><\/p>\n\n\n\n

Facilitateur d\u2019innovation biopharma<\/em><\/p>\n\n\n\n

Le CQDM est un consortium de recherche biopharmaceutique \u00e0 but non lucratif dont la mission est de soutenir et de faciliter la recherche et d\u00e9veloppement collaborative multipartite visant \u00e0 acc\u00e9l\u00e9rer la translation ou la transformation de technologies innovantes en solutions r\u00e9pondant \u00e0 des besoins m\u00e9dicaux non satisfaits, tout en g\u00e9n\u00e9rant des retomb\u00e9es significatives pour l\u2019\u00e9conomie qu\u00e9b\u00e9coise et canadienne. Pour plus d\u2019informations, consultez le site web https:\/\/www.cqdm.org<\/a> et rejoignez-nous sur Twitter\/X @CQDM_Canada<\/a> et LinkedIn<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

9Bio Th\u00e9rapeutiques est fi\u00e8re d\u2019annoncer un investissement strat\u00e9gique du Merck Digital Sciences Studio (MDSS) et du CQDM. Ce financement permettra d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement de la plateforme de d\u00e9couverte guid\u00e9e par calcul de 9Bio ainsi que de son pipeline de th\u00e9rapies tumorales s\u00e9lectives.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-2002","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"\n9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program - 9Bio Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/9biotx.com\/fr\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program - 9Bio Therapeutics\" \/>\n<meta property=\"og:description\" content=\"9Bio Therapeutics is proud to announce a strategic investment from the Merck Digital Sciences Studio (MDSS) and CQDM. The funding will accelerate the development of 9Bio\u2019s computationally guided discovery platform and pipeline of tumor-selective therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/9biotx.com\/fr\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/\" \/>\n<meta property=\"og:site_name\" content=\"9Bio Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-23T16:13:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T14:24:53+00:00\" \/>\n<meta name=\"author\" content=\"Henrique de Carvalho\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Henrique de Carvalho\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/\"},\"author\":{\"name\":\"Henrique de Carvalho\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/#\\\/schema\\\/person\\\/eda3764256a793b2350112b46b0169a8\"},\"headline\":\"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program\",\"datePublished\":\"2025-06-23T16:13:24+00:00\",\"dateModified\":\"2026-01-20T14:24:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/\"},\"wordCount\":770,\"publisher\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/\",\"url\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/\",\"name\":\"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program - 9Bio Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/#website\"},\"datePublished\":\"2025-06-23T16:13:24+00:00\",\"dateModified\":\"2026-01-20T14:24:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/news\\\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/9biotx.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/#website\",\"url\":\"https:\\\/\\\/9biotx.com\\\/\",\"name\":\"9Bio Therapeutics\",\"description\":\"Engineering Biological Possibilities\",\"publisher\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/9biotx.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/#organization\",\"name\":\"9Bio Therapeutics\",\"url\":\"https:\\\/\\\/9biotx.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/9biotx.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/9Bio-therapeutics-transparent-background-tangerine-small.png\",\"contentUrl\":\"https:\\\/\\\/9biotx.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/9Bio-therapeutics-transparent-background-tangerine-small.png\",\"width\":200,\"height\":80,\"caption\":\"9Bio Therapeutics\"},\"image\":{\"@id\":\"https:\\\/\\\/9biotx.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/9bio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/9biotx.com\\\/#\\\/schema\\\/person\\\/eda3764256a793b2350112b46b0169a8\",\"name\":\"Henrique de Carvalho\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0627e8f747d51e00b97aadc1c41d88c0c04f1f314d881b75f519fbbc5468f8a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0627e8f747d51e00b97aadc1c41d88c0c04f1f314d881b75f519fbbc5468f8a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0627e8f747d51e00b97aadc1c41d88c0c04f1f314d881b75f519fbbc5468f8a?s=96&d=mm&r=g\",\"caption\":\"Henrique de Carvalho\"},\"sameAs\":[\"https:\\\/\\\/9bio.ca\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program - 9Bio Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/9biotx.com\/fr\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/","og_locale":"fr_CA","og_type":"article","og_title":"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program - 9Bio Therapeutics","og_description":"9Bio Therapeutics is proud to announce a strategic investment from the Merck Digital Sciences Studio (MDSS) and CQDM. The funding will accelerate the development of 9Bio\u2019s computationally guided discovery platform and pipeline of tumor-selective therapies.","og_url":"https:\/\/9biotx.com\/fr\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/","og_site_name":"9Bio Therapeutics","article_published_time":"2025-06-23T16:13:24+00:00","article_modified_time":"2026-01-20T14:24:53+00:00","author":"Henrique de Carvalho","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Henrique de Carvalho","Estimation du temps de lecture":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/#article","isPartOf":{"@id":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/"},"author":{"name":"Henrique de Carvalho","@id":"https:\/\/9biotx.com\/#\/schema\/person\/eda3764256a793b2350112b46b0169a8"},"headline":"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program","datePublished":"2025-06-23T16:13:24+00:00","dateModified":"2026-01-20T14:24:53+00:00","mainEntityOfPage":{"@id":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/"},"wordCount":770,"publisher":{"@id":"https:\/\/9biotx.com\/#organization"},"articleSection":["News"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/","url":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/","name":"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program - 9Bio Therapeutics","isPartOf":{"@id":"https:\/\/9biotx.com\/#website"},"datePublished":"2025-06-23T16:13:24+00:00","dateModified":"2026-01-20T14:24:53+00:00","breadcrumb":{"@id":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/9biotx.com\/news\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/9biotx.com\/"},{"@type":"ListItem","position":2,"name":"9Bio Therapeutics selected by the Merck Digital Sciences Studio and CQDM for strategic investment and acceleration program"}]},{"@type":"WebSite","@id":"https:\/\/9biotx.com\/#website","url":"https:\/\/9biotx.com\/","name":"9Bio Th\u00e9rapeutiques","description":"Engineering Biological Possibilities","publisher":{"@id":"https:\/\/9biotx.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/9biotx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/9biotx.com\/#organization","name":"9Bio Th\u00e9rapeutiques","url":"https:\/\/9biotx.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/9biotx.com\/#\/schema\/logo\/image\/","url":"https:\/\/9biotx.com\/wp-content\/uploads\/2024\/10\/9Bio-therapeutics-transparent-background-tangerine-small.png","contentUrl":"https:\/\/9biotx.com\/wp-content\/uploads\/2024\/10\/9Bio-therapeutics-transparent-background-tangerine-small.png","width":200,"height":80,"caption":"9Bio Therapeutics"},"image":{"@id":"https:\/\/9biotx.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/9bio\/"]},{"@type":"Person","@id":"https:\/\/9biotx.com\/#\/schema\/person\/eda3764256a793b2350112b46b0169a8","name":"Henrique de Carvalho","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/d0627e8f747d51e00b97aadc1c41d88c0c04f1f314d881b75f519fbbc5468f8a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d0627e8f747d51e00b97aadc1c41d88c0c04f1f314d881b75f519fbbc5468f8a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d0627e8f747d51e00b97aadc1c41d88c0c04f1f314d881b75f519fbbc5468f8a?s=96&d=mm&r=g","caption":"Henrique de Carvalho"},"sameAs":["https:\/\/9bio.ca"]}]}},"taxonomy_info":{"category":[{"value":1,"label":"News"}]},"featured_image_src_large":false,"author_info":{"display_name":"Henrique de Carvalho","author_link":"https:\/\/9biotx.com\/fr\/news\/author\/decarvalho\/"},"comment_info":11,"category_info":[{"term_id":1,"name":"News","slug":"news","term_group":0,"term_taxonomy_id":1,"taxonomy":"category","description":"9Bio News","parent":0,"count":7,"filter":"raw","cat_ID":1,"category_count":7,"category_description":"9Bio News","cat_name":"News","category_nicename":"news","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/posts\/2002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/comments?post=2002"}],"version-history":[{"count":5,"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/posts\/2002\/revisions"}],"predecessor-version":[{"id":2053,"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/posts\/2002\/revisions\/2053"}],"wp:attachment":[{"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/media?parent=2002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/categories?post=2002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/9biotx.com\/fr\/wp-json\/wp\/v2\/tags?post=2002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}